Marksans Pharma Market Cap

Marksans Pharma has a market cap or net worth of 100.82 billion as of March 31, 2025. Its market cap has increased by 53.22% in one year.

Market Cap

100.82B

Enterprise Value

96.32B

Revenue

24.74B

Ranking

n/a

PE Ratio

27.36

Stock Price

222.00

Market Cap Chart

Since December 13, 2006, Marksans Pharma's market cap has increased from 36.52B to 100.82B, an increase of 176.09%. That is a compound annual growth rate of 5.71%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	100.82B	-25.01%
Dec 31, 2024	134.43B	84.14%
Dec 29, 2023	73.00B	210.96%
Dec 30, 2022	23.48B	-4.66%
Dec 31, 2021	24.63B	-0.80%
Dec 31, 2020	24.82B	263.17%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,162.13B
Divi's Laboratories	1,533.20B
Cipla	1,164.75B
Mankind Pharma	1,000.40B
Apollo Hospitals Enterprise	951.31B
Zydus Lifesciences	891.93B
Aurobindo Pharma	674.02B
Alkem Laboratories	583.68B

Market Cap Rankings